ID

21966

Descripción

Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT00190268

Link

https://clinicaltrials.gov/show/NCT00190268

Palabras clave

  1. 10/5/17 10/5/17 -
Subido en

10 de mayo de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Multiple Sclerosis NCT00190268

Eligibility Multiple Sclerosis NCT00190268

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age >= 18 years and = <60 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
patients with multiple sclerosis clinically defined and with mifs-sep score > 44, without deficit sleep and without depression.
Descripción

Multiple Sclerosis Modified Fatigue Impact Scale Questionnaire | Sleep loss Absent | Depressive disorder Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0026769
UMLS CUI [1,2]
C3810705
UMLS CUI [2,1]
C0235161
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0011581
UMLS CUI [3,2]
C0332197
patients without treatment by 3,4-dap since 3 months
Descripción

3,4-diaminopyridine Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0046948
UMLS CUI [1,2]
C0332197
edss score < 6
Descripción

Kurtzke multiple sclerosis rating scale

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0451246
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
asat/alat > 2 x uln
Descripción

Aspartate aminotransferase increased | Alanine aminotransferase increased

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
madrs >= 20
Descripción

Montgomery-Asberg Depression Rating Scale Questionnaire

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4054475
abnormality cardiac rhythm
Descripción

Cardiac Arrhythmia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0003811
pregnancy
Descripción

Pregnancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
asthma
Descripción

Asthma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004096
evolutive affection
Descripción

Progressive Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1335499
renal failure
Descripción

Kidney Failure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0035078

Similar models

Eligibility Multiple Sclerosis NCT00190268

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age >= 18 years and = <60 years
boolean
C0001779 (UMLS CUI [1])
Multiple Sclerosis Modified Fatigue Impact Scale Questionnaire | Sleep loss Absent | Depressive disorder Absent
Item
patients with multiple sclerosis clinically defined and with mifs-sep score > 44, without deficit sleep and without depression.
boolean
C0026769 (UMLS CUI [1,1])
C3810705 (UMLS CUI [1,2])
C0235161 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0011581 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
3,4-diaminopyridine Absent
Item
patients without treatment by 3,4-dap since 3 months
boolean
C0046948 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Kurtzke multiple sclerosis rating scale
Item
edss score < 6
boolean
C0451246 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
asat/alat > 2 x uln
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Montgomery-Asberg Depression Rating Scale Questionnaire
Item
madrs >= 20
boolean
C4054475 (UMLS CUI [1])
Cardiac Arrhythmia
Item
abnormality cardiac rhythm
boolean
C0003811 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Asthma
Item
asthma
boolean
C0004096 (UMLS CUI [1])
Progressive Disease
Item
evolutive affection
boolean
C1335499 (UMLS CUI [1])
Kidney Failure
Item
renal failure
boolean
C0035078 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial